tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

Atara Biotherapeutics Inc

ATRA
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
8.380USD
+0.210+2.57%
์ข…๊ฐ€ย 07-31 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
60.42M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

Atara Biotherapeutics Inc

8.380
+0.210+2.57%
๊ฐœ์š”
๊ธˆ์œต
ํ† ๋ก 
๋ถ„์„
ํšŒ์‚ฌ
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ

๊ฐœ์š”

๊ธˆ์œต

ํ† ๋ก 

๋ถ„์„

ํšŒ์‚ฌ

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ

ATRA ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Atara Biotherapeutics Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

Atara Biotherapeutics Inc ์‹ค์  ๋ฐœํ‘œ์ผ

์ตœ์‹  ์ถœ์‹œ
May 12, 2026
EPS / ์˜ˆ์ƒ
-0.49/-0.41
์ˆ˜์ต / ์˜ˆ์ƒ
516.00K/2.85M
์˜ˆ์ •๋œ ์‹ค์  ๋ฐœํ‘œ ์ผ์ • ๋ณด๊ธฐ >>
์ฃผ๊ธฐ
FY2025 ์žฌ๋ฌด์ œํ‘œ
์ˆ˜์ต(YoY)
120.77M
-6.33%
EPS(YoY)
2.61
122.85%
์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€
BUY
2026/08/01
๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
YOY
๋นˆ ํ–‰ ์ˆจ๊ธฐ๊ธฐ
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-108.34%-0.29
78.90%-0.25
89.19%-0.32
105.04%0.20
162.54%3.53
91.52%-1.19
82.11%-2.93
77.04%-3.88
68.60%-5.65
22.66%-13.97
---16.40
---16.92
---17.98
---18.07
---37.83
----
----
----
----
----
์ˆ˜์ต
-99.47%516.00K
-95.13%1.59M
-91.41%3.45M
-38.63%17.57M
258.77%98.15M
670.30%32.75M
1779.79%40.19M
2892.69%28.64M
2131.40%27.36M
1823.98%4.25M
-52.05%2.14M
-98.14%957.00K
-83.24%1.23M
-97.07%221.00K
-16.96%4.46M
1232.79%51.58M
105.91%7.31M
--7.55M
--5.37M
--3.87M
์ˆœ์ด์ต
-110.91%-4.14M
73.17%-3.41M
80.36%-4.30M
112.53%2.39M
219.71%38.01M
79.00%-12.69M
68.61%-21.91M
73.21%-19.05M
57.53%-31.75M
18.94%-60.45M
17.00%-69.80M
-485.08%-71.11M
15.13%-74.77M
20.11%-74.57M
0.68%-84.09M
122.04%18.47M
-12.47%-88.11M
-14.81%-93.35M
-13.88%-84.66M
-8.18%-83.79M
์ˆœ์ด์ต๋ฅ 
-2174.26%-803.29%
-451.02%-213.54%
-128.60%-124.62%
120.42%13.58%
133.37%38.73%
97.27%-38.75%
98.33%-54.51%
99.10%-66.51%
98.10%-116.07%
95.79%-1421.68%
---3264.59%
---7430.30%
---6098.78%
---33742.99%
---242.66%
----
----
----
----
----
์ด ์ด์ต๋ฅ 
-4.05%75.97%
17.95%93.48%
19.22%96.67%
15.51%96.85%
-14.63%79.18%
208.60%79.25%
463.44%81.08%
141.40%83.84%
12.58%92.74%
-74.32%25.68%
---22.31%
---202.51%
--82.38%
--100.00%
--100.00%
----
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
208.03%207.40%
454.31%209.65%
410.52%138.05%
241.60%109.00%
204.73%67.33%
64.07%37.82%
49.54%27.04%
138.65%31.91%
108.96%22.10%
149.98%23.05%
--18.08%
--13.37%
--10.57%
--9.22%
--1.25%
----
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์ˆ˜์ต
-99.47%516.00K
-95.13%1.59M
-91.41%3.45M
-38.63%17.57M
258.77%98.15M
670.30%32.75M
1779.79%40.19M
2892.69%28.64M
2131.40%27.36M
1823.98%4.25M
-52.05%2.14M
-98.14%957.00K
-83.24%1.23M
-97.07%221.00K
-16.96%4.46M
1232.79%51.58M
105.91%7.31M
--7.55M
--5.37M
--3.87M
์˜์—… ์ด์ต
-106.39%-3.37M
89.21%-1.32M
83.70%-3.55M
126.41%4.72M
298.95%52.72M
77.10%-12.20M
68.75%-21.76M
74.97%-17.88M
64.66%-26.50M
29.40%-53.28M
11.58%-69.61M
-122.25%-71.41M
15.02%-74.97M
19.20%-75.47M
7.17%-78.73M
61.75%-32.13M
-12.75%-88.22M
-14.33%-93.40M
-13.53%-84.81M
-7.76%-84.00M
์ˆœ์ด์ต
-110.91%-4.14M
73.17%-3.41M
80.36%-4.30M
112.53%2.39M
219.71%38.01M
79.00%-12.69M
68.61%-21.91M
73.21%-19.05M
57.53%-31.75M
18.94%-60.45M
17.00%-69.80M
-485.08%-71.11M
15.13%-74.77M
20.11%-74.57M
0.68%-84.09M
122.04%18.47M
-12.47%-88.11M
-14.81%-93.35M
-13.88%-84.66M
-8.18%-83.79M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
-55.22%12.17M
-81.18%12.21M
-79.93%18.43M
-60.31%24.77M
-74.46%27.18M
-36.30%64.89M
-22.61%91.86M
-63.78%62.41M
-52.52%106.43M
-65.48%101.87M
-58.06%118.70M
-50.34%172.32M
-28.69%224.18M
-23.28%295.08M
-23.40%283.05M
-11.56%346.98M
-32.29%314.39M
-26.50%384.62M
8.86%369.50M
9.29%392.32M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
-88.21%5.64M
-88.91%14.92M
-88.42%18.06M
-90.18%14.56M
-73.49%47.89M
-5.38%134.57M
97.22%155.98M
98.88%148.27M
166.21%180.69M
80.22%142.23M
9.47%79.09M
13.49%74.55M
-33.17%67.88M
-25.40%78.92M
-16.14%72.24M
-26.05%65.69M
20.63%101.56M
27.61%105.79M
138.94%86.15M
180.36%88.83M
์ด ์ž์‚ฐ
-67.77%20.00M
-81.45%20.23M
-78.86%30.17M
-68.54%36.90M
-62.46%62.04M
-34.08%109.10M
-24.41%142.71M
-52.41%117.28M
-45.29%165.27M
-56.03%165.50M
-48.74%188.79M
-43.49%246.44M
-23.96%302.08M
-19.59%376.42M
-18.14%368.32M
-4.53%436.12M
-24.99%397.28M
-20.40%468.13M
10.95%449.92M
6.70%456.79M
๋ถ€์ฑ„ ์ด๊ณ„
-51.06%57.31M
-71.54%58.74M
-71.36%66.80M
-68.47%71.94M
-55.57%117.11M
-22.04%206.38M
-2.66%233.25M
-4.53%228.15M
11.16%263.58M
5.99%264.74M
32.24%239.63M
33.78%238.99M
37.09%237.12M
32.50%249.78M
29.63%181.20M
42.62%178.64M
32.44%172.96M
49.87%188.51M
170.91%139.78M
166.58%125.25M
์ž๋ณธ ์ด๊ณ„
32.25%-37.31M
60.42%-38.50M
59.54%-36.63M
68.39%-35.04M
43.98%-55.07M
1.96%-97.28M
-78.09%-90.54M
-1587.36%-110.87M
-251.34%-98.31M
-178.36%-99.23M
-127.17%-50.84M
-97.11%7.45M
-71.04%64.96M
-54.71%126.64M
-39.67%187.11M
-22.34%257.48M
-43.79%224.32M
-39.52%279.61M
-12.37%310.14M
-13.01%331.54M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
89.08%-3.07M
76.72%-5.70M
-145.35%-9.79M
31.25%-7.32M
4.98%-28.14M
51.45%-24.47M
92.23%-3.99M
79.84%-10.64M
22.94%-29.61M
11.38%-50.41M
21.08%-51.35M
17.46%-52.80M
54.54%-38.43M
-65.98%-56.88M
-10.31%-65.06M
-3.88%-63.96M
-28.66%-84.53M
-731.77%-34.27M
-11.37%-58.98M
-8.72%-61.58M
์ˆœํˆฌ์ž
-100.00%0.00
150.00%8.44M
85.47%-2.42M
-170.46%-5.07M
16.86%17.20M
-66.05%3.38M
-123.66%-16.66M
-85.46%7.20M
345.00%14.72M
-80.58%9.94M
18.01%70.45M
55.48%49.48M
-109.98%-6.01M
310.57%51.22M
4899.75%59.70M
-0.20%31.83M
346.07%60.22M
34.07%-24.32M
-84.21%1.19M
124.46%31.89M
์ˆœ์žฌ๋ฌดํ™œ๋™
1280.40%2.95M
99.09%-3.00K
-97.07%1.05M
4823.46%15.30M
-101.04%-250.00K
-121.69%-328.00K
17308.17%35.79M
-168.79%-324.00K
10172.77%24.14M
-95.32%1.51M
2.80%-208.00K
-59.29%471.00K
-98.82%235.00K
-37.26%32.29M
-100.45%-214.00K
-52.72%1.16M
586.41%19.85M
-71.21%51.47M
40.68%47.14M
-98.72%2.45M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Atara Biotherapeutics Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atara Biotherapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 120.77M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 128.94M์ž…๋‹ˆ๋‹ค.

Atara Biotherapeutics Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atara Biotherapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 12.21M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -81.18์ž…๋‹ˆ๋‹ค.

Atara Biotherapeutics Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atara Biotherapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Atara Biotherapeutics Inc์˜ ์ด์ž์‚ฐ์€ 20.23M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -81.45์ž…๋‹ˆ๋‹ค.

Atara Biotherapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atara Biotherapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Atara Biotherapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” 58.74M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -71.54์ž…๋‹ˆ๋‹ค.

Atara Biotherapeutics Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atara Biotherapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Atara Biotherapeutics Inc์˜ ์ด์ž๋ณธ์€ -38.50M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 60.42์ž…๋‹ˆ๋‹ค.

Atara Biotherapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atara Biotherapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Atara Biotherapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ 52.57M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 167.11์ž…๋‹ˆ๋‹ค.

Atara Biotherapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atara Biotherapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Atara Biotherapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” 18.15M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 110.44์ž…๋‹ˆ๋‹ค.

Atara Biotherapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atara Biotherapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Atara Biotherapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 16.10M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -72.85์ž…๋‹ˆ๋‹ค.

Atara Biotherapeutics Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atara Biotherapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ 2.61์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 122.85์ž…๋‹ˆ๋‹ค.

Atara Biotherapeutics Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atara Biotherapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ 32.69M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 138.28์ž…๋‹ˆ๋‹ค.

Atara Biotherapeutics Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atara Biotherapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ 27.07์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 140.86์ž…๋‹ˆ๋‹ค.

Atara Biotherapeutics Inc์˜ ๋งค์ถœ์ด์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atara Biotherapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์ด์ด์ต๋ฅ ์€ 82.44์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -1.52์ž…๋‹ˆ๋‹ค.

Atara Biotherapeutics Inc์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atara Biotherapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 209.65์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 454.31์ž…๋‹ˆ๋‹ค.

Atara Biotherapeutics Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atara Biotherapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ 50.55์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 181.27์ž…๋‹ˆ๋‹ค.

Atara Biotherapeutics Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Atara Biotherapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ 52.57M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 167.11์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ